Data as at IST. Index data may be delayed by up to 20 minutes. For real-time updates, kindly refer to the BSE and NSE websites.
ERIS Lifesciences Share Price
Know More₹1,451.15 273.70 (23.25%)
16-Jan-2026BSE : 540596
NSE : ERIS
Sector : Health care
ISIN Code : INE406M01024
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 16-Jan-2026
| Market Cap (₹ Cr) | 19,750 |
Traded Value (₹ Cr) | 0.09 |
Volume (Shares) | 631 |
Face Value (₹) | 1 |
52-Week High (₹) | 1,909.55 |
52-Week High Date | 12-Jun-2025 |
52-Week Low (₹) | 1,130.05 |
52-Week Low Date | 28-Jan-2025 |
All Time High (₹) | 1,909.55 |
All Time High Date | 12-Jun-2025 |
All Time Low (₹) | 341.05 |
All Time Low Date | 30-Mar-2020 |
ERIS Lifesciences Ltd
ERIS Lifesciences Ltd News
ERIS Lifescience Announcement
ERIS Lifesciences Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 19,750 |
| EPS - TTM (₹) [C] | 32.96 |
| P/E Ratio (X) [C] | 44.03 |
| Face Value (₹) | 1 |
| Latest Dividend (%) | 735.00 |
| Latest Dividend Date | 13-Feb-2025 |
| Dividend Yield (%) | 0.51 |
| Book Value Share (₹) [C] | 226.93 |
| P/B Ratio (₹) [C] | 6.39 |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| HDFC Small Cap Fund (G) | 706.33 | 59,71,657 | 2.51 |
| HDFC Small Cap Fund (IDCW) | 706.33 | 59,71,657 | 2.51 |
| HDFC Small Cap Fund - Direct (G) | 706.33 | 59,71,657 | 2.51 |
| HDFC Small Cap Fund - Direct (IDCW) | 706.33 | 59,71,657 | 2.51 |
| HDFC Hybrid Equity Fund (G) | 290.92 | 24,59,629 | 1.31 |
| HDFC Hybrid Equity Fund (IDCW) | 290.92 | 24,59,629 | 1.31 |
| HDFC Hybrid Equity Fund - Direct (IDCW) | 290.92 | 24,59,629 | 1.31 |
| HDFC Hybrid Equity Fund - Direct (G) | 290.92 | 24,59,629 | 1.31 |
| Franklin India Small Cap Fund (G) | 220.81 | 18,66,828 | 1.96 |
| Franklin India Small Cap Fund (IDCW) | 220.81 | 18,66,828 | 1.96 |
Load more
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 1,444.00 1,472.05 |
| Week Low/High (₹) | 602.80 1,472.05 |
| Month Low/High (₹) | 602.80 1,472.05 |
| Year Low/High (₹) | 1,130.05 1,910.00 |
| All time Low/High (₹) | 341.05 1,910.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | 130.78% | 130.89% | 40.85% | 45.95% |
| 1 Month | 119.46% | 119.72% | 36.34% | 40.93% |
| 3 Month | 99.50% | 99.62% | 37.37% | 42.33% |
| 6 Month | 106.03% | 105.55% | 43.22% | 47.77% |
| 1 Year | 106.41% | 106.63% | 42.16% | 46.32% |
| 3 Year | 173.03% | 174.55% | 109.59% | 119.46% |
Company Info
Company Information
Registered Office: 8th Floor Commerce House -IV, Prahladnagar 100 FT Road,Ahmedabad,Gujarat-380015 Ph: 91-79-30451000
FAQs about ERIS Lifesciences Ltd
1. What's the ERIS Lifesciences Ltd share price today?
ERIS Lifesciences Ltd share price was Rs 1,451.15 at close on 16th Jan 2026. ERIS Lifesciences Ltd share price was up by 23.25% over the previous closing price of Rs 1,177.45. ERIS Lifesciences Ltd share price trend:
- Last 1 Month: ERIS Lifesciences Ltd share price moved up by 119.46% on BSE.
- Last 3 Months: ERIS Lifesciences Ltd share price moved up by 99.50% on BSE.
- Last 12 Months: ERIS Lifesciences Ltd share price moved up by 106.41% on BSE.
- Last 3 Years: ERIS Lifesciences Ltd share price moved up by 173.03% on BSE.
2. How can I quickly analyse the performance of the ERIS Lifesciences Ltd stock?
The performance of the ERIS Lifesciences Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 44.03
- Price to book value ratio is 6.39
- Dividend yield of 0.51
- The EPS (trailing 12 months) of the ERIS Lifesciences Ltd stock is Rs 32.96
3. What is the market cap of ERIS Lifesciences Ltd?
ERIS Lifesciences Ltd has a market capitalisation of Rs 19,750 crore.
4. What is ERIS Lifesciences Ltd's 52-week high/low share price?
The ERIS Lifesciences Ltd’s 52-week high share price is Rs 1,909.55 and 52-week low share price is Rs 1,130.05.
5. Is the ERIS Lifesciences Ltd profitable?
On a consolidated basis, ERIS Lifesciences Ltd reported a profit of Rs 86.93 crore on a total income of Rs 731.67 crore for the quarter ended 2024.
6. Which are ERIS Lifesciences Ltd’s peers in the Health care sector?
ERIS Lifesciences Ltd’s top 5 peers in the Health care sector are Piramal Pharma, Pfizer, Astrazeneca Phar, ERIS Lifescience, Sai Life, Neuland Labs., Jubilant Pharmo.
7. Who owns how much in ERIS Lifesciences Ltd?
Key changes to the ERIS Lifesciences Ltd shareholding are as follows:
- Promoter holding in ERIS Lifesciences Ltd has gone up to 52.70 per cent as of Dec 2022 from 52.66 per cent as of Mar 2022.